Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

6.12USD
20 Apr 2018
Change (% chg)

$-0.07 (-1.13%)
Prev Close
$6.19
Open
$6.18
Day's High
$6.18
Day's Low
$6.08
Volume
5,835
Avg. Vol
54,681
52-wk High
$15.78
52-wk Low
$4.42

Select another date:

Tue, Jan 16 2018

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

Select another date: